Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-08-29

Clinical Trial Update: Survey on Long-Term Use of BI-Sifrol® Tablets in Patients With Restless Legs Syndrome

View source ↗

Summary

This is a completed clinical trial update reporting results of a long-term use survey of BI-Sifrol tablets in patients with Restless Legs Syndrome. Results were…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • BI-Sifrol (pramipexole)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Restless Legs Syndrome | Status: COMPLETED | Results posted: 2014-08-29